Norris Medicines Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

9.93

9.93

9.93

9.93

9.93

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

-22.37

-20.62

-17.36

-12.39

-9.55

Loan funds

Secured loans

18.43

18.10

15.52

14.98

11.24

Unsecured loans

-

-

-

-

-

Total

5.98

7.41

8.09

12.51

11.61

Uses of funds

Fixed assets

Gross block

27.95

27.92

27.87

27.78

27.70

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

21.48

20.85

20.20

19.53

18.80

Net block

6.47

7.07

7.67

8.25

8.90

Capital work-in-progress

-

-

-

-

-

Investments

0.01

0.01

0.01

0.01

0.01

Net current assets

Current assets, loans & advances

7.21

7.11

12.11

12.30

11.48

Less : current liabilities & provisions

7.70

6.78

11.69

8.04

8.77

Total net current assets

-0.50

0.33

0.41

4.26

2.70

Miscellaneous expenses not written

-

-

-

-

-

Total

5.98

7.41

8.09

12.51

11.61

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

1.33

1.33

1.33

-

-

Number of equity sharesoutstanding (Lacs)

100.01

100.01

100.01

100.01

100.01